Cemex S.A.B. De C.V. Sponsored (CX) 10.38 $CX CEMEX's

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cemex S.A.B. De C.V. Sponsored (CX) 10.38 $CX

CEMEX's (CX) CEO Fernando González on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 23, 6:24PM CDT

CX: 10.38 (+0.24)

Cemex SAB DE CV (CX) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Thu Apr 23, 5:18PM CDT
The following Cemex SAB DE CV (CX) conference call took place on April 23, 2015, 10:00 AM ET. This is a transcript of that earnings call:
CX: 10.38 (+0.24)

Cemex, S.A.B. de C.V. (CX) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Apr 23, 8:55AM CDT

CX: 10.38 (+0.24)

Cemex reports Q1 results
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 6:45AM CDT

CX: 10.38 (+0.24)

CEMEX Reports First-Quarter 2015 Results
Business Wire - Thu Apr 23, 6:30AM CDT
CEMEX, S.A.B. de C.V. ("CEMEX" (NYSE: CX), announced today that consolidated net sales reached US$3.4 billion during the first quarter of 2015, an increase of 7% on a like-to-like basis for the ongoing operations and adjusting for currency fluctuations, versus the comparable period in 2014. Operating EBITDA increased by 6% during the quarter to US$569 million versus the same period in 2014. On a like-to-like basis, operating EBITDA increased by 14% in the same period.
CX: 10.38 (+0.24)

Watch for Cemex SAB de CV to Potentially Pullback After Gaining 2.40% Yesterday
Comtex SmarTrend(R) - Wed Apr 22, 5:06PM CDT
Cemex SAB de CV (NYSE:CX) traded in a range yesterday that spanned from a low of $9.77 to a high of $10.07. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $10.02 on volume of 14.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CX: 10.38 (+0.24)

Look for Shares of Cemex SAB de CV to Potentially Pullback after Yesterday's 2.40% Rise
Comtex SmarTrend(R) - Wed Apr 22, 5:05PM CDT
Cemex SAB de CV (NYSE:CX) traded in a range yesterday that spanned from a low of $9.77 to a high of $10.07. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $10.02 on volume of 14.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CX: 10.38 (+0.24)

How it All Plays Out: Free Research on General Electric, Cemex, Comcast, Sirius XM, and Rite Aid
PR Newswire - Wed Apr 22, 7:40AM CDT
Editor Note: For more information about this release, please scroll to bottom.
CX: 10.38 (+0.24), GE: 26.80 (-0.05), CMCSA: 59.64 (+0.41), SIRI: 3.96 (+0.03), RAD: 8.25 (-0.01)

What's in Store for PulteGroup (PHM) this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 1:59PM CDT
PulteGroup Inc. (PHM) is set to report first quarter 2015 results on Apr 23, before the market opens.
CBI: 48.97 (-2.13), CX: 10.38 (+0.24), PHM: 20.12 (+0.15), TOL: 36.80 (+0.75)

Will D.R. Horton (DHI) Surprise Earnings Estimates in Q2? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 20, 1:30PM CDT
D.R. Horton Inc. (DHI) is set to report second-quarter fiscal 2015 results on Apr 22, before the market opens.
CBI: 48.97 (-2.13), DHI: 26.57 (+0.42), CX: 10.38 (+0.24), TOL: 36.80 (+0.75)

After Yesterday's Rally of 2.76% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Apr 15, 4:57PM CDT
Cemex SAB de CV (NYSE:CX) traded in a range yesterday that spanned from a low of $9.75 to a high of $10.13. Yesterday, the shares gained 2.8%, which took the trading range above the 3-day high of $9.87 on volume of 20.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CX: 10.38 (+0.24)

Construction Materials Stocks on our Scanner -- Cemex, Vulcan Materials, Eagle Materials, Martin Marietta Materials, and Headwaters
PR Newswire - Tue Apr 14, 7:55AM CDT
Editor Note: For more information about this release, please scroll to bottom.
MLM: 138.53 (+0.29), CX: 10.38 (+0.24), VMC: 83.47 (+1.14), EXP: 84.36 (+0.42), HW: 18.54 (+0.01)

CEMEX Denounces Timeshare Fraud
Business Wire - Mon Apr 13, 4:30PM CDT
CEMEX, S.A.B. de C.V. ("CEMEX" (NYSE:CX) announced today that third parties not affiliated to CEMEX are illegally using different means, including CEMEX's logo, forged signatures and other information, in unauthorized and fraudulent offers to purchase timeshares in Mexico on behalf of CEMEX and/or CEMEX executives.
CX: 10.38 (+0.24)

CEMEX Latam Holdings to Report First Quarter 2015 Results on April 23, 2015
Business Wire - Fri Apr 10, 4:10PM CDT
CEMEX Latam Holdings, S.A. ("CLH" (BVC:CLH), announced today that it will report its first quarter 2015 results on Thursday, April 23, 2015.
CX: 10.38 (+0.24), CLH: 55.94 (+0.01)

Look for Shares of Cemex SAB de CV to Potentially Pullback after Yesterday's 4.11% Rise
Comtex SmarTrend(R) - Mon Apr 06, 5:38PM CDT
Cemex SAB de CV (NYSE:CX) traded in a range yesterday that spanned from a low of $9.71 to a high of $10.16. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $9.85 on volume of 17.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CX: 10.38 (+0.24)

BUYINS.NET: CX, NNI, CONN, ASR, CF, PUI Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Tue Mar 31, 7:41AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Cemex SAB de CV (NYSE:CX), Nelnet Inc (NYSE:NNI), CONN'S, INC. (NASDAQ:CONN), Alacer Gold Corp (NYSE:ASR), Canaccord Financial Inc (NYSE:CF), Powershares Dynamic Utilities Portfolio (NYSEUI) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
CX: 10.38 (+0.24), PUI: 23.01 (+0.14), CF: 294.44 (+4.67), ASR: 151.54 (+0.95), CONN: 30.85 (+0.15), NNI: 45.62 (-0.13)

Benefiting From Mexico's Energy Reforms
Marla Backer - at Seeking Alpha - Fri Mar 27, 4:15PM CDT

CX: 10.38 (+0.24)

Cemex earmarks $100M of assets for sale
Seeking Alpha - at Seeking Alpha - Fri Mar 27, 6:38AM CDT

CX: 10.38 (+0.24)

CEMEX Announces Interest Rate and Initial Conversion Rate Applicable to Its Convertible Notes Due 2020
Business Wire - Wed Mar 25, 3:05PM CDT
CEMEX, S.A.B. de C.V. ("CEMEX" (NYSE: CX) announced today that the interest rate of its U.S.$200 million in aggregate principal amount of Convertible Subordinated Notes due 2020 (the "Convertible Notes" is 3.720% and the initial conversion rate of the Convertible Notes is 80.7735 of CEMEX's American Depositary Shares (the "ADSs" per U.S.$1,000 principal amount of the Convertible Notes.
CX: 10.38 (+0.24)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Yiren Digital Faces Class Action by Investors

Updated Category News Views 71

Yiren's Stormy Seas: A Tale of Instability If you're holding a stake in Yiren Digital Ltd. (NYSE: YRD), you're likely feeling the heat right now. It's been a ride down a bumpy road with stock prices taking a nosedive—plummeting 44.05% on news that's got investors seeing red. The Nuts and Bolts of the Class Action What's the big fuss, you ask? Well, the lawsuit is no...

Continue Reading
Lululemon Faces Class Action Amid Sales Decline

Updated Category News Views 20

Looks like Lululemon Athletica Inc. (NASDAQ: LULU) is in the hot seat, and not in the cozy yoga session kind of way. Investors are gearing up for a legal face-off thanks to a class action lawsuit alleging some serious corporate sleight of hand. What Triggered This Legal Storm? Turns out, between March 18 and September 3, 2026, things didn't go as planned for Lululemon....

Continue Reading
Bark Tech Expands Disability Access with New Approvals

Updated Category News Views 30

Redefining Accessibility through Technology Tech giant Bark is making waves with its fresh blueprint for accessible technology. Recently, Wisconsin gave a nod to Bark Phone and Bark Watch through the state’s IRIS and CLTS programs, aiming to support individuals with disabilities. This development could reshape our understanding of technology beyond the binary choice of...

Continue Reading
BETR Investors Face Deadline in Class Action Case

Updated Category News Views 50

Investor Deadline Looms for BETR Losses Ah, the tangled web of finance promises and posturing! Investors in Better Home & Finance Holding Company (NASDAQ: BETR) are now standing at a financial crossroads, thanks to an unfolding legal drama. You've got until November 20, 2026, to align your ducks and join a federal securities class action lawsuit, put forth by Hagens...

Continue Reading
2026 Midterms: Bond Market Shifts Investors Eye

Updated Category News Views 54

Reassessing Bonds Post-2026 Midterms When the election circus packs up its tents, investors like us are left standing in the wreckage, trying to figure out what's next for our portfolios. That's just where One Oak Capital Management's latest research fits into our jigsaw—exploring how the political winds can ripple through the layers of the bond market. Federal...

Continue Reading
CorelDRAW's Flexibility: A Designer's One-Time Buy?

Updated Category News Views 49

CorelDRAW: A Design Powerhouse Without Recurring Bills? Every so often, a software option comes along that piques my interest, and right now, it's CorelDRAW Graphics Suite. Consumer365 has shone a light on this nifty tool for its one-time purchase model—a breath of fresh air in the age of endless subscriptions that seem to drain more than enthusiasm as the months roll...

Continue Reading
INOVIO's $75M Offering: A Tough Medicine for Investors

Updated Category News Views 27

A Shot in the Arm or a Sore Spot? INOVIO Pharmaceuticals is diving headfirst into the capital markets with a $75 million public offering, and let me tell you, the road ahead isn't paved with gold, yet. They've set out to raise funds by pricing 58,747,235 shares at $1.05 a pop, which might have you scratching your head if you're holding INO shares already. Breaking Down...

Continue Reading
Mobile Health Program Drives Down Hospital Visits

Updated Category News Views 8

The wheels are literally in motion in South Broward, with Memorial Healthcare System's Mobile Health Program taking healthcare to the doorstep of thousands. This killer initiative slashed hospital admissions by a nifty 62% among its users in 2025, and they ain't slowing down in 2026. Talk about bringing the doctor to the streets and changing lives! Healthcare On Wheels:...

Continue Reading
Hanon Systems Reports 2026 Q3 Results: Profit Soars

Updated Category News Views 102

Profit Surges Despite Revenue Dip When a company's profit jumps up while sales take a slight nosedive, they're doing something right—or maybe they've got a lucky rabbit's foot. Hanon Systems just rolled out their numbers for Q3 2026, and here's what's cooking: operating profit soared a whopping 26.6% year-on-year to hit KRW 120.6 billion, even while revenue stumbled a...

Continue Reading
Clean Energy: How COP31 Can Change the Future

Updated Category News Views 97

Global Warming: A Battle Heating Up Fast It's like trying to run uphill while carrying the baggage of outdated promises. We’ve got business bigwigs rallying at COP31, demanding the world to get serious about clean energy. If they don’t, we're looking at warming rocketing up to 2.6°C come year 2100. Who's listening though? The Call for Clean Electrification This mob,...

Continue Reading

Top 5 Most Recently Viewed Articles

Rhythm Pharmaceuticals Reports Strong Q4 2024 Revenues and Plans Ahead

Updated Category News Views 254

Rhythm Pharmaceuticals' Financial Performance for Q4 2024 Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company dedicated to helping patients with rare neuroendocrine diseases, recently unveiled its preliminary financial results for the last quarter and the entirety of 2024. It has been reported that the company anticipates net revenues from global...

Continue Reading
Investors Find Path to Justice in Rocket Lab Fraud Case

Updated Category News Views 404

Understanding the Rocket Lab Securities Fraud Case The recent developments surrounding Rocket Lab USA, Inc. (NASDAQ: RKLB) have created a significant opportunity for investors seeking justice. If you purchased Rocket Lab securities within a specific time frame, you may find that legal action could be a path to compensation for potential losses incurred due to misleading...

Continue Reading
Allegiant Unveils New Nonstop Flights to Exciting Destinations

Updated Category News Views 128

Allegiant Expands Nonstop Routes with Exciting New Additions Allegiant Travel Company (NASDAQ: ALGT) has just announced an exciting expansion of its nonstop flight routes, adding connections to eight diverse cities. This initiative reflects Allegiant's commitment to serving travelers with budget-friendly options that help make dream vacations a reality. As the airline...

Continue Reading
Class Action Lawsuit Against Solaris Energy: What Investors Must Know

Updated Category News Views 165

Understanding the Class Action Lawsuit Against Solaris Energy Infrastructure Investors are being alerted about a significant class action lawsuit involving Solaris Energy Infrastructure, Inc. (NYSE: SEI). This development has the potential to impact numerous shareholders, making it crucial for investors to stay informed. Details of the Allegations The lawsuit alleges...

Continue Reading
ARTHEx Biotech Set to Showcase Innovations at Healthcare Event

Updated Category News Views 223

ARTHEx Biotech Participates in Healthcare Conference ARTHEx Biotech S.L. is stepping into the spotlight as it prepares for participation in a prominent virtual healthcare conference. This event, known as the 24th Annual Needham Virtual Healthcare Conference, will serve as a platform for the company to engage with potential investors and showcase its advancements in...

Continue Reading